|
Trillium Therapeutics Inc. is #15 in rating Capitalization on NCM.
Trillium Therapeutics Inc. earnings per share rating is compiled based on the results of financial statements on earnings. Earnings per share - the stock exchange characteristic of the company, which shows the share of profit reduced to 1 share. The “earnings per share” rating is growing for those companies in which, as a rule, earnings per share are also growing.
Rating Trillium Therapeutics Inc. net income - a rating compiled by the total amount of the company's income for the reporting financial period. The company's income or profit for the Net Income rating does not consider the total number of shares of the company and their value. Those companies whose profits are the most by absolute value and are at the top of the Net Income rating list.
|
